Inventor
CHOO QUI-LIM
US42 patents
⚠️ This page may combine multiple inventors who share the name “CHOO QUI-LIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIRON CORP
31 patentsUS5712145AJan 27, 1998
Hepatitis C virus protease
CHIRON CORP112 citations99
US5683864ANov 4, 1997
Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
CHIRON CORP159 citations99
US5350671ASep 27, 1994
HCV immunoassays employing C domain antigens
CHIRON CORP218 citations99
US6171782B1Jan 9, 2001
Antibody compositions to HCV and uses thereof
CHIRON CORP85 citations98
US6027729AFeb 22, 2000
NANBV Diagnostics and vaccines
CHIRON CORP95 citations98
US5712087AJan 27, 1998
Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
CHIRON CORP101 citations98
US5597691AJan 28, 1997
Hepatitis C virus protease
CHIRON CORP86 citations97
US5371017ADec 6, 1994
Hepatitis C virus protease
CHIRON CORP87 citations97
US6312889B1Nov 6, 2001
Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
CHIRON CORP68 citations96
US6096541AAug 1, 2000
Cell culture systems for HCV
CHIRON CORP62 citations96
US6074816AJun 13, 2000
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
CHIRON CORP75 citations96
US5885799AMar 23, 1999
Hepatitis C virus protease
CHIRON CORP42 citations96
US5863719AJan 26, 1999
Methods for detecting hepatitis C virus using polynucleotides specific for same
CHIRON CORP70 citations96
US5714596AFeb 3, 1998
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
CHIRON CORP120 citations96
US5712088AJan 27, 1998
Methods for detecting Hepatitis C virus using polynucleotides specific for same
CHIRON CORP106 citations96
US5698390ADec 16, 1997
Hepatitis C immunoassays
CHIRON CORP62 citations96
US5585258ADec 17, 1996
Hepatitis C virus protease
CHIRON CORP75 citations96
US6274148B1Aug 14, 2001
Hepatitis C virus asialoglycoproteins
CHIRON CORP55 citations95
US6194140B1Feb 27, 2001
HCV NS3 protein fragments having helicase activity and improved solubility
CHIRON CORP54 citations95
US6074852AJun 13, 2000
Hepatitis C virus asialoglycoproteins
CHIRON CORP53 citations95
US5989905ANov 23, 1999
HCV NS3 protein fragments having helicase activity and improved solubility
CHIRON CORP51 citations95
US5942234AAug 24, 1999
Hepatitis C virus asialoglycoproteins
CHIRON CORP74 citations95
US5378814AJan 3, 1995
Hepatitis delta viral polypeptides
CHIRON CORP52 citations94
US6521423B1Feb 18, 2003
Intracellular production of Hepatitis C E2 polypeptides
CHIRON CORP32 citations91
US5389528AFeb 14, 1995
Hepatitis δ diagnostics and vaccines
CHIRON CORP10 citations81
US7033805B2Apr 25, 2006
HCV NS3 protein fragments having helicase activity and improved solubility
CHIRON CORP8 citations73
US6472180B1Oct 29, 2002
HCV NS3 protein fragments having helicase activity and improved solubility
CHIRON CORP8 citations73
US5932219AAug 3, 1999
Hepatitis delta virus p27.sup.δ and p24.sup.δ vaccine
CHIRON CORP9 citations71
US5750350AMay 12, 1998
Hepatitis δ diagnostics
CHIRON CORP4 citations71
US5747044AMay 5, 1998
Hepatitis delta diagnostics and vaccines
CHIRON CORP7 citations71
US6861212B1Mar 1, 2005
NANBV diagnostics and vaccines
CHIRON CORP5 citations63
NANSHA BIOLOGICS HONG KONG LTD
4 patentsUS11931417B2Mar 19, 2024
Methods of preparing a pegylated human IL-11 composition
NANSHA BIOLOGICS HONG KONG LTD0 citations58
US10946103B2Mar 16, 2021
Methods of treatment using a branched amino terminal pegylated Il-11 composition
NANSHA BIOLOGICS HONG KONG LTD0 citations58
US10881739B2Jan 5, 2021
Interleukin-11 PEGylation reaction intermediate composition
NANSHA BIOLOGICS HONG KONG LTD0 citations58
US10335492B2Jul 2, 2019
Increasing serum half-life of human IL-11 variants by N-terminal branched PEGylation
NANSHA BIOLOGICS HONG KONG LTD0 citations47
NOVARTIS VACCINES & DIAGNOSTIC
3 patentsUS7105303B2Sep 12, 2006
Antibodies to hepatitis C virus asialoglycoproteins
NOVARTIS VACCINES & DIAGNOSTIC44 citations95
US7790366B1Sep 7, 2010
NANBV diagnostics and vaccines
NOVARTIS VACCINES & DIAGNOSTIC15 citations93
US7429385B2Sep 30, 2008
Intracellular production of hepatitis C E1 and E2 truncated polypeptides
NOVARTIS VACCINES & DIAGNOSTIC6 citations72